BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Jennifer Kim does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 PGENPrecigen Inc | Buy | — | May 2025 | +193.9% | — |
 BLTEBelite Bio Inc ADR | Buy | — | May 2025 | +111.1% | — |
| BLTEBelite Bio Inc ADR | Buy | — | Mar 2025 | +136.4% | — |
 FBIOFortress Biotech Inc | Buy | — | Jun 2024 | +8.8% | — |
 EYPTEyepoint Pharmaceuticals Inc | Buy | — | Jun 2024 | +7.6% | — |
| BLTEBelite Bio Inc ADR | Buy | — | Jun 2024 | +32.9% | — |
| PGENPrecigen Inc | Buy | — | May 2024 | +2.8% | — |
| FBIOFortress Biotech Inc | Buy | $5.00 | Aug 2023 | −88.4% | Miss |
 LPCNLipocine Inc | Buy | $33.00 | Jul 2023 | −0.5% | Miss |
 PRQRProQR Therapeutics BV | Buy | $4.50 | May 2023 | −3.2% | Miss |
| FBIOFortress Biotech Inc | Buy | $5.00 | May 2023 | −96.4% | Miss |
 AYTUAytu BioScience Inc | Buy | $5.00 | May 2022 | −87.6% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.